Literature DB >> 18482555

The disparity of cervical cancer in diverse populations.

Levi S Downs1, Jennifer S Smith, Isabel Scarinci, Lisa Flowers, Groesbeck Parham.   

Abstract

Significant disparities in cervical cancer incidence and mortality rates among minority groups have been documented in the United States, despite an overall decline in these rates for the population as a whole. Differences in cervical cancer screening practices have been suggested as an explanation for these disparities, as have differences in treatment among various racial and ethnic groups. A number of factors are attributed to these observed differences. As minority populations continue to grow in size over the next 50 years, persistent disparities will place an ever increasing burden on these populations and on the national healthcare system. Strategies to reduce cervical cancer disparities need to be employed in order to reverse these trends.

Entities:  

Mesh:

Year:  2008        PMID: 18482555     DOI: 10.1016/j.ygyno.2008.01.003

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  75 in total

1.  Opportunities to improve cervical cancer screening in the United States.

Authors:  Jane J Kim
Journal:  Milbank Q       Date:  2012-03       Impact factor: 4.911

2.  Examining barriers to cervical cancer screening and treatment in Florida through a socio-ecological lens.

Authors:  Ellen Daley; Amina Alio; Erica H Anstey; Rasheeta Chandler; Karen Dyer; Hannah Helmy
Journal:  J Community Health       Date:  2011-02

3.  Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries.

Authors:  Lindsey Enewold; Jing Zhou; Katherine A McGlynn; Susan S Devesa; Craig D Shriver; John F Potter; Shelia H Zahm; Kangmin Zhu
Journal:  Cancer       Date:  2011-08-11       Impact factor: 6.860

4.  Racial disparities in human papillomavirus vaccination: does access matter?

Authors:  Amanda Gelman; Elizabeth Miller; Eleanor Bimla Schwarz; Aletha Y Akers; Kwonho Jeong; Sonya Borrero
Journal:  J Adolesc Health       Date:  2013-08-27       Impact factor: 5.012

Review 5.  FDG-PET in gynaecological cancers: recent observations.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11       Impact factor: 9.236

6.  Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age.

Authors:  Carolyn E Banister; Amy R Messersmith; Bo Cai; Lisa B Spiryda; Saundra H Glover; Lucia Pirisi; Kim E Creek
Journal:  J Infect Dis       Date:  2014-07-15       Impact factor: 5.226

7.  HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border.

Authors:  Maria E Fernandez; Sheryl A McCurdy; Sarah R Arvey; Sandra K Tyson; Daisy Morales-Campos; Belinda Flores; Bernardo Useche; Lisa Mitchell-Bennett; Maureen Sanderson
Journal:  Ethn Health       Date:  2009-12       Impact factor: 2.772

8.  Public health national approach to reducing breast and cervical cancer disparities.

Authors:  Jacqueline W Miller; Marcus Plescia; Donatus U Ekwueme
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

9.  Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.

Authors:  Eric R Gamazon; Navin Pinto; Anuar Konkashbaev; Hae Kyung Im; Sharon J Diskin; Wendy B London; John M Maris; M Eileen Dolan; Nancy J Cox; Susan L Cohn
Journal:  J Natl Cancer Inst       Date:  2012-12-14       Impact factor: 13.506

10.  Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states.

Authors:  Mira L Katz; Paul L Reiter; Brenda C Kluhsman; Stephenie Kennedy; Sharon Dwyer; Nancy Schoenberg; Andy Johnson; Gretchen Ely; Karen A Roberto; Eugene J Lengerich; Pamela Brown; Electra D Paskett; Mark Dignan
Journal:  Vaccine       Date:  2009-04-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.